Onto Innovation Expands Customer Collaborations with Investment in Training, Demonstration and Solutions Development Centers in Asia
August 24 opening of center located in Korea to be followed by a center in Taiwan later in the year...
Alex
Alex is a writer and digital content enthusiast who enjoys covering technology, current trends, useful tips, and topics that matter to everyday readers. With a focus on clear, informative, and easy-to-understand content, Alex aims to provide readers with practical insights and interesting perspectives across a wide range of subjects.
Intelsat Commercial Aviation goes into Agreement with Nelco to Offer Inflight Connectivity in India’s Airspace
Intelsat enters India’s untapped commercial airline market MCLEAN, Va. and MUMBAI, India--(BUSINESS WIRE)--Intelsat, operator of one of the world’s largest...
FIS to Modernize Real-Time Payments Infrastructure and Central Bank Digital Currencies for Countries Around the World
Key facts FIS is now offering a central infrastructure payment solution through RealNet™ Central, which enables countries to modernize or...
Biocytogen Expands Partnership with Merck KGaA, Darmstadt, Germany
BEIJING & DARMSTADT, Germany--(BUSINESS WIRE)--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen") entered into a global licensing agreement with Merck KGaA, Darmstadt,...
Nighthawk Gold Completes 2022 Exploration Program Drilling Ahead of Schedule
TORONTO--(BUSINESS WIRE)--$MIMZF #commodities--Nighthawk Gold Corp. (“Nighthawk” or the “Company”) (TSX: NHK; OTCQX: MIMZF) is pleased to report the completion of...
Avanci Signs Agreements with Hyundai and Kia
South Korean automakers join Avanci’s essential patent marketplace for connected vehicles DALLAS--(BUSINESS WIRE)--Today, Avanci announced that it has signed patent...
Clinical Data from the LIGHT-UP Study Presented at the International Congress of Endocrinology Suggests New Gelesis Oral Hydrogel May Improve Insulin Sensitivity and Favorably Impact Metabolic Syndrome
The 25-week weight loss study which achieved its previously reported primary endpoints also examined the effects of GS200 on insulin...
Grab Reports Second Quarter 2022 Results
Q2 record Revenue of $321 million, up 79% year-over-year Q2 GMV of $5.1 billion, up 30% year-over-year Q2 Loss for...
Genius Group Enters into a Securities Purchase Agreement for US$18.13 Million Private Placement
SINGAPORE--(BUSINESS WIRE)--$GNS #GNS--Genius Group Limited (“Genius Group” or the “Company”) (NYSE American: GNS), a world-leading entrepreneur Edtech and education group,...
LYNPARZA® (olaparib) Approved in Japan as Adjuvant Treatment for Patients With BRCA-Mutated, HER2-Negative High Recurrent Risk Breast Cancer
First and only PARP inhibitor to improve invasive disease-free survival, the primary endpoint, and overall survival, a key secondary endpoint...
Hansen Powers Customer Care and Billing for Allente
MELBOURNE, Australia--(BUSINESS WIRE)--Hansen Technologies (ASX:HSN), a leading global provider of software and services to the energy, water and communications industries,...
PropertyGuru Reports Second Quarter 2022 Results
Revenues Grow 44% Year Over Year in Second Quarter and 43% in First Half Total revenue of S$33.0 million in...
BLOCWARS Operator Blocverse DAO Announces Acquisition of Swagga Studio to Create Phygital Fashion Metaverse
NEW YORK--(BUSINESS WIRE)--Blocverse DAO, the operator of play-to-earn (P2E) project BLOCWARS, announces the acquisition of IP creator Swagga Studio to...
eCloudvalley Is One of The Best Companies to Work for in Asia 2022
SINGAPORE--(BUSINESS WIRE)--eCloudvalley Digital Technology was recently named one of the Best Companies to Work for in Asia by the leading...
Genexine selected for Late-Breaking Oral Presentation of Phase 2 Study of GX-188E in Combination with KEYTRUDA® (pembrolizumab) in Cervical Cancer at European Society for Medical Oncology (ESMO) Congress 2022
SEOUL, South Korea--(BUSINESS WIRE)--Genexine (KOSDAQ: 095700), a publicly traded, clinical-stage Korean biopharmaceutical company committed to the discovery and development of...
